REGISTER TODAY to take advantage of special member SAVINGS

Register as a MassBio member and save $200!

When registering as a MassBio member, please note “MassBio Member - $200 discount” in the comments field to be sure this special rate is used.

 

 

This year the MassBio Investors Forum goes global!

The BioPharm America 2010/MassBio Investors Forum will be held on September 15-17 at the Copley Marriott in Boston, MA.

Meet new potential partners, catch up on current relationships, and see company presentations featuring the best and brightest technologies.

Join companies like:

Adimab Inc	Algol Pharma
Anchor Therapeutics	Bayer Schering Pharma AG
Biogen Idec	BioSante Pharmaceuticals, Inc
Cephalon	Cerulean Pharma Inc.
Cubist Pharmaceuticals	Elan Drug Technologies
Eli Lilly and Company	Genta Incorporated
Idera Pharmaceuticals, Inc	Japan Tobacco Pharma
Johnson & Johnson	Logical Therapeutics
Mersana Therapeutics, Inc	Novacta Biosystems Ltd
Novartis	Novartis Option Fund
On-Q-ity	Pacific Biometrics, Inc.
Pervasis Therapeutics	Recordati
Revotar Biopharmaceuticals AG	SANOFI AVENTIS R & D
Scientia Advisors	Supernus Pharmaceuticals, Inc.
Taligen Therapeutics	Tempero Pharmaceuticals, Inc.
The Leukemia & Lymphoma Society	Third Rock Ventures
UCB

Present alongside companies including:

4s3 Bioscience	AbGenomics
Acetylon Pharmaceuticals	Amarantus Therapeutics
Anchor Therapeutics	BioBehavioral Diagnostics
BioSante Pharmaceuticals	Cerulean Pharma
Chiome Bioscience	CUREMARK
Elan Drug Technologies	Eurand
Flex Biomedical	Genfit
Genta Incorporated	Idera Pharmaceuticals
Immunovaccine	INAGEN
Intelliject	Logical Therapeutics
MacroGenics	mondobiotech
Oncolix	Ora
Otonomy	Oxygen Biotherapeutics
PDS Biotechnology Corporation	PELVIPHARM
Pergamum AB	PolyMedix
Rentschler Biotechnologie GmbH	Shanghai Medicilon
StemCellRX	Supernus Pharmaceuticals
Syndax	Taligen Therapeutics
Tempero Pharmaceuticals	Tetraphase Pharmaceuticals
TransPharma Medical	Vybion
Vetter Pharma

 

In partnership with BioPharm America, the MassBio Investors Forum will convene companies from across the globe to partner and invest in Massachusetts’s most innovative companies.

MassBio and EBD Group will make this combined event North America’s premiere partnering conference -- creating a unique, high powered business exchange uniting international and world class life sciences companies at one location for three days.

Our panels will tackle the most critical issues facing the industry today, including:

• Regenerative Medicine: Bridging the Gap Between Science and Commercial Success
• In-licensing Strategy: Who's the One for You?
• Building a Sustainable Business in Biotech
• Financing for Phase I/II Assets
• Bridging the Valley of Death: Who will Finance Innovation?
• Strategic Investments and Alliances: Is Corporate Venture Replacing Traditional Venture Capital?
• (Global) Collaborative Business Models
• Serial Entrepreneurs: What Makes Them Do It Again, and Again, and Again?
• Driving Personalized Medicine: The New Business Model Among Rx, Dx, Medtech and Payors

 

Conference speakers include:

Mara Aspinall, President and CEO,On-Q-Ity

Deborah Dunsire, President and CEO, Millennium: The Takeda Oncology Company

Alan Ezekowitz, Senior VP, Merck & Co., Inc.

Mark Levin, Partner,Third Rock Ventures

John Mendlein, Chairman,, Fate Therapeutics

Sridaran Natesan – Scientific Site Head of R&D, Cambridge & Head of External Innovation and Partnering, US, Northeast, sanofi-aventis

Garry Neil, Corporate VP, Johnson & Johnson

Brock C. Reeve, Executive Director, Harvard Stem Cell Institute

James Sabry, VP, Genentech

Ed Torres, Managing Director, Lilly Ventures

Patrick Vallance, Head, Medicines Discovery and Development, GlaxoSmithKline

Christoph Westphal, Former CEO and Co-founder, Momenta, Alnylam and Sirtris

 

BONUS SESSION!

Translational Medicine Program on Friday, Sept. 17^th

Exploring Early Stage Partnerships

This program will focus on the successes and challenges at the interface of academic science and company start-up and licensing. Academia has traditionally focused on leveraging federal dollars to promulgate basic research for the purpose of answering scientific questions. In the life sciences, exploring many of these scientific questions has led to breakthrough discoveries such as RNAi. On the industry side, commercialization of these products to fulfill unmet medical needs depends on the successful translation of scientific ideas into application. The “innovation gap” is the failure to successfully and efficiently bridge the conversion of scientific findings into products or companies that manufacture products based on those scientific ideas.

 

Why should your organization be there?

Biotech companies: Engage in private meetings, networking activities and company presentation opportunities with potential investors from around the world.

Pharma companies: If you are a Pharma company looking for early and/or later stage opportunities, you will have a chance to forge relationships with academia, disease foundations and biotech companies.

Disease foundations: Form partnerships with biotech and Pharma companies around programs addressing your patient constituencies; meet with leading academicians in your therapeutic space.

Venture capitalists: Hear presenting companies ranging from early stage to public companies seeking to raise capital.

Corporate Strategics: Meet leaders of emerging companies useful to your strategies for pipeline growth; see the next ground-breaking technologies, first-in-class, best-in-class compounds.

Academic Medical Centers: You are the engines of innovation! Come meet your future industrial collaborators. Meet the heads of business and corporate development and CEO’s of Biotech companies and pharma companies. They want to meet you!

 

BioPharm America 2010/MassBio Investors Forum promises to be a must-attend event where life science leaders engage in discussion and collaboration to take our industry through the next decade and beyond.

For more information, visit http://www.ebdgroup.com/bpa/.

 

View the complete calendar or more info about MassBio signature events.

 

 

 

For more information, visit http://www.ebdgroup.com/bpa/.